Saverio Alberti, PhD, MD Head of Medical Genetics, University of Messina, Italy. Biography Saverio Alberti obtained his MD degree in 1979 Magna cum laude from Ferrara University. In 1982 he obtained his PhD degree in Pharmacological Research at the Institute Mario Negri, Milano, with Silvio Garattini. In 1982 he obtained his specialty in Oncology from Ferrara University. In 1986 he became Fellow in Genetics, after a 4-year post-doc in the Department of Genetics, at Stanford University with Luca Cavalli Sforza, in Human Genetics and Len Herzenberg, in Immunogenetics. Saverio Alberti spent sabbaticals c/o Sir Peter Medawar, Nobel Prize laureate, Transplantation Section CRC (Harrow, UK), Hiromitsu Nakauchi, Human Frontier Science Institute - RIKEN (Tsukuba, Japan), Joseph Schlessinger, New York University, Ivan Morrison, ILRAD (Nairobi, Kenia). He has acquired long-standing experience in cancer biology and immunotherapy, molecular biology, regulation of gene expression, mechanisms of genome stability, DNA methylation. He is recognized leader in the field of Trop molecules. His research group has cloned the genes, biochemically characterized Trop-1 and -2, identified their function as drivers of tumor progression, and developed cancer-selective anti-Trop-2 immunotherapy, ADC, bispecifics, CAR-T. Saverio Alberti holds 12 families of patents on biotech applications to cancer diagnosis and therapy and has been awarded 28 grants at national and international levels.